Key statistics
On Friday, ACADIA Pharmaceuticals Inc (ACAD:NSQ) closed at 16.53, 13.61% above the 52 week low of 14.55 set on Jun 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.41 |
---|---|
High | 16.59 |
Low | 16.18 |
Bid | 15.50 |
Offer | 16.90 |
Previous close | 16.42 |
Average volume | 952.21k |
---|---|
Shares outstanding | 165.88m |
Free float | 164.99m |
P/E (TTM) | 91.17 |
Market cap | 2.74bn USD |
EPS (TTM) | 0.1813 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
- Ryan Reynolds Announces More to Parkinson’s® Campaign
- Acadia Pharmaceuticals to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview
- Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024
- Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med
More ▼